the Affiliated Hospital of Yangzhou University, Yangzhou University
Yangzhou, Jiangsu, China
NCT Number: NCT06237478
Glycopyrrolate is an anticholinergic medication commonly used in respiratory medicine for treating chronic obstructive pulmonary disease (COPD), bronchial asthma, and other conditions . In the perioperative period, it is often administered before anesthesia to reduce secretions in the salivary glands, bronchi, and pharynx . It is used during the recovery period to counteract the muscarinic effects of anticholinesterase inhibitors and can also be employed to prevent/treat vagal reflexes and related arrhythmias induced by surgery or medications .
Heart rate (HR) is influenced by both the sympathetic and parasympathetic nervous systems. The baseline HR of different patients may vary due to differing levels of sympathetic and parasympathetic nerve activity within the body. It remains unclear whether patients with different baseline HRs exhibit varying degrees of HR elevation after the administration of glycopyrrolate(i.e.,the parasympathetic activity in vivo is antagonized). The primary aim of this study is to explore the impact of glycopyrrolate administration on HR in patients with different baseline HRs. The secondary objective is to investigate the effects of glycopyrrolate on heart rate variability (HRV) in patients with different baseline HR.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Yangzhou, Jiangsu, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At the timepoint of 10 min after operation beginning (T1), the basic HR, MAP and the HRV frequency indexes were recorded. Then glycopyrrolate 0.006 mg/kg was injected intravenously in Group L.
Time frame: before induction of general anesthesia; 10 min after operation beginning; 30 min after glycopyrrolate injection
Calculation of the maximum increase of HR (∆HR): The increase in heart rate (HR) at 30 minutes after the administration of glycopyrrolate (T2) compared to 10 minutes after the start of surgery (T1) was calculated as the maximum increase of HR.
Time frame: before induction of general anesthesia; 10 min after operation beginning; 30 min after glycopyrrolate injection
The maximum increase ratio of HR =∆HR/[HR at T1]) .
Time frame: before induction of general anesthesia; 10 min after operation beginning; 30 min after glycopyrrolate injection
HRV frequency indexes included Low frequency power (LF, 0.04-0.15 Hz), High frequency power (HF, 0.15-0.4 Hz) and LF/HF.
Zhuan Zhang
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05693246
Glycopyrrolate
Yangzhou, Jiangsu, China
View Trial DetailsNCT04401345
Cardiovascular Diseases, Effect of Drug
Dharān, Koshi, Nepal
View Trial DetailsNCT06948409
Anesthesia, Atropine
Boston, Massachusetts, United States
View Trial Details